{"id":"https://openalex.org/W2912928331","doi":"https://doi.org/10.1182/blood-2018-99-118675","title":"Overcoming a Critical Obstacle Towards Effective and Safe CAR T-Cell Therapeutics","display_name":"Overcoming a Critical Obstacle Towards Effective and Safe CAR T-Cell Therapeutics","alternate_titles":[],"publication_year":2018,"publication_date":"2018-11-29","ids":{"openalex":"https://openalex.org/W2912928331","doi":"https://doi.org/10.1182/blood-2018-99-118675","mag":"2912928331"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2018-99-118675","doi":"https://doi.org/10.1182/blood-2018-99-118675","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2018-99-118675","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2912928331"],"child_works_count":0,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5012062301","display_name":"Nandini Mondal","orcid":"https://orcid.org/0000-0001-9508-3280","observed_orcids":["https://orcid.org/0000-0001-9508-3280","https://orcid.org/0000-0003-0814-9021"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Nandini Mondal","raw_affiliation_strings":["Department of Dermatology, Brigham and Women's Hospital, Boston, MA","Program of Excellence in Glycosciences, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, Brigham and Women's Hospital, Boston, MA","institution_ids":["https://openalex.org/I1283280774"]},{"raw_affiliation_string":"Program of Excellence in Glycosciences, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100377471","display_name":"Mariana Camoesas Silva","orcid":"https://orcid.org/0009-0002-8546-4164","observed_orcids":["https://orcid.org/0009-0002-8546-4164"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Mariana Silva","raw_affiliation_strings":["Department of Dermatology, Brigham and Women's Hospital, Boston, MA","Program of Excellence in Glycosciences, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, Brigham and Women's Hospital, Boston, MA","institution_ids":["https://openalex.org/I1283280774"]},{"raw_affiliation_string":"Program of Excellence in Glycosciences, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047900893","display_name":"Ana P. Casta\u00f1o","orcid":"https://orcid.org/0000-0002-5214-030X","observed_orcids":["https://orcid.org/0000-0002-5214-030X"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Ana Castano","raw_affiliation_strings":["Massachusetts General Hospital Cancer Center, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital Cancer Center, Boston, MA","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029763484","display_name":"Marcela Valderrama Maus","orcid":"https://orcid.org/0000-0002-7578-0393","observed_orcids":["https://orcid.org/0000-0002-7578-0393"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marcela V. Maus","raw_affiliation_strings":["Massachusetts General Hospital Cancer Center, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital Cancer Center, Boston, MA","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5103273503","display_name":"Robert Sackstein","orcid":"https://orcid.org/0000-0003-1757-891X","observed_orcids":["https://orcid.org/0000-0003-1757-891X"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert Sackstein","raw_affiliation_strings":["Department of Dermatology, Brigham and Women's Hospital, Boston, MA","Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA","Program of Excellence in Glycosciences, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, Brigham and Women's Hospital, Boston, MA","institution_ids":["https://openalex.org/I1283280774"]},{"raw_affiliation_string":"Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984"]},{"raw_affiliation_string":"Program of Excellence in Glycosciences, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5012062301","https://openalex.org/A5047900893","https://openalex.org/A5100377471"],"corresponding_institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984","https://openalex.org/I4210087915"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"132","issue":"Supplement 1","first_page":"2056","last_page":"2056"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/car-t-cell-therapy","display_name":"CAR T-cell therapy","score":0.8600000143051147},{"id":"https://openalex.org/keywords/e-selectin","display_name":"E-selectin","score":0.9100000262260437},{"id":"https://openalex.org/keywords/sialyl-lewis-x","display_name":"sialyl Lewis X","score":0.9980000257492065},{"id":"https://openalex.org/keywords/t-cell-extravasation","display_name":"T cell extravasation","score":0.6240000128746033},{"id":"https://openalex.org/keywords/glioblastoma","display_name":"glioblastoma","score":0.902999997138977},{"id":"https://openalex.org/keywords/egfr","display_name":"EGFR","score":0.5120000243186951},{"id":"https://openalex.org/keywords/t-cell-expansion","display_name":"T cell expansion","score":0.550000011920929},{"id":"https://openalex.org/keywords/microfluidic-flow-chamber","display_name":"microfluidic flow chamber","score":0.652999997138977},{"id":"https://openalex.org/keywords/shear-stress","display_name":"shear stress","score":0.4659999907016754},{"id":"https://openalex.org/keywords/endothelial-cell-adhesion","display_name":"endothelial cell adhesion","score":0.4650000035762787},{"id":"https://openalex.org/keywords/cytokine-release-syndrome","display_name":"cytokine release syndrome","score":0.6359999775886536},{"id":"https://openalex.org/keywords/neurotoxicity","display_name":"neurotoxicity","score":0.9169999957084656},{"id":"https://openalex.org/keywords/sialic-acid","display_name":"sialic acid","score":0.4309999942779541},{"id":"https://openalex.org/keywords/leukemia-relapse","display_name":"leukemia relapse","score":0.36800000071525574}],"concepts":[{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5027651786804199},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.48052892088890076},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.478675901889801},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.47326043248176575},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.46022918820381165},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4441164433956146},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3453930914402008},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.2578415274620056},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2018-99-118675","doi":"https://doi.org/10.1182/blood-2018-99-118675","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2018-99-118675","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3130907588","https://openalex.org/W2981307368","https://openalex.org/W7154722761","https://openalex.org/W4406417350","https://openalex.org/W1976683089","https://openalex.org/W2151967247","https://openalex.org/W4319160489","https://openalex.org/W2606140146","https://openalex.org/W4403510830","https://openalex.org/W2954111468"],"abstract_inverted_index":{"Abstract":[0],"Chimeric":[1],"Antigen":[2],"Receptor":[3],"(CAR)":[4],"T-cells":[5,107,128,138,195,220,240,252,291,306,333,346,427,510,527,542,568],"have":[6],"shown":[7],"great":[8],"promise":[9],"in":[10,161,229,504],"achieving":[11,58],"stable":[12],"remission":[13],"of":[14,28,68,77,104,136,163,199,224,258,279,289,402,414,419,442,455,484,496,507,525,573,592],"B":[15],"cell":[16,54,186,314,328,554,574,586],"acute":[17],"lymphoblastic":[18],"leukemia":[19],"and":[20,31,47,71,94,146,265,343,581,583,588],"are":[21,307,534],"being":[22],"utilized":[23,300],"to":[24,51,82,119,152,193,246,292,320,387,416,440,469,487,512,521,528,530],"treat":[25],"a":[26,87,282,301,412,477],"variety":[27],"other":[29],"hematologic":[30],"non-hematologic":[32],"malignancies.":[33],"However,":[34],"this":[35,354,593],"therapy":[36],"is":[37,73],"associated":[38],"with":[39,139,154,182,281,318,325],"significant":[40],"adverse":[41],"effects":[42],"(e.g.,":[43],"cytokine":[44],"release":[45],"syndrome":[46],"neurotoxicity),":[48],"largely":[49],"related":[50],"the":[52,287,326,365,403,420,460,472,579],"high":[53],"doses":[55],"requisite":[56],"for":[57,75,166,176],"therapeutic":[59,595],"response(s).":[60],"E-selectin,":[61],"an":[62,488,522],"endothelial":[63,313,350,437],"molecule":[64],"expressed":[65],"on":[66,96,201,263,276,338,364,435],"microvessels":[67],"bone":[69],"marrow":[70,505],"tumors,":[72],"critical":[74],"extravasation":[76],"blood-borne":[78],"cells.":[79,98],"E-selectin":[80,125,294,322,474,489,544,558],"binds":[81],"sialyl":[83],"Lewis":[84],"X":[85],"(sLeX),":[86],"sialofucosylated":[88],"tetrasaccharide":[89],"motif":[90],"decorating":[91],"specialized":[92],"glycoproteins":[93],"glycolipids":[95],"circulating":[97],"Given":[99],"that":[100,218,269,380,441,450,539],"better":[101],"site-specific":[102],"delivery":[103],"administered":[105],"CAR":[106,127,141,239,251,283,290,345,366,393,404,426,444,526,567],"would":[108],"yield":[109],"more":[110],"efficacious":[111],"immunotherapy":[112],"while":[113,249,407],"limiting":[114],"off-target":[115],"effects,":[116],"we":[117,299,356,481],"sought":[118],"determine":[120],"whether":[121,358,471],"these":[122,517],"cells":[123,144,148,173,190,438,486],"express":[124],"ligands.":[126],"targeting":[129],"glioblastoma":[130,185],"were":[131,150,174,191],"created":[132],"by":[133,158,180,213,553],"lentiviral":[134],"transduction":[135,280],"human":[137,310],"anti-EGFR-BBz-mCherry":[140],"construct.":[142,284],"Transduced":[143],"(T)":[145],"untransduced":[147],"(UT)":[149],"subjected":[151],"stimulation":[153],"anti-CD3/CD28":[155],"microbeads":[156],"followed":[157],"culture":[159,270,451,540],"expansion":[160,271,452,587],"presence":[162],"interleukin-2":[164],"(IL2)":[165],"10":[167],"days":[168,179],"(\"10\").":[169],"In":[170],"some":[171],"cases,":[172],"expanded":[175,541],"7":[177],"additional":[178],"co-culturing":[181],"irradiated":[183],"U87":[184],"line":[187],"(\"17\").":[188],"These":[189],"compared":[192,245,439,511],"resting":[194],"(non-expanded;":[196],"NE).":[197],"Expression":[198],"sLeX":[200,225,244,259,274,330,359,395,400,409,548],"each":[202],"T-cell":[203,367,394,405,422],"population":[204],"(NE,":[205],"T10,":[206],"T17,":[207],"UT10":[208,264],"or":[209],"UT17)":[210],"was":[211,261],"measured":[212],"flow":[214,303],"cytometry.":[215],"We":[216,499],"observed":[217,262,327,501],"NE":[219,247,332,421],"display":[221,241,334,428,549],"moderate":[222],"expression":[223,260,275,360,410],"as":[226],"previously":[227],"reported":[228],"literature":[230],"(Silva,":[231],"Fung":[232],"et":[233],"al.,":[234],"J.":[235],"Immunol.,":[236],"2017).":[237],"T10":[238,342],"significantly":[242],"lower":[243],"T-cells,":[248,277],"T17":[250,344],"completely":[253],"lack":[254,543],"sLeX.":[255,388],"Similar":[256],"pattern":[257],"UT17":[266],"populations,":[267,406],"indicating":[268],"progressively":[272],"depletes":[273],"regardless":[278],"To":[285,352],"analyze":[286],"capacity":[288],"bind":[293],"under":[295],"hemodynamic":[296],"shear":[297],"conditions,":[298],"microfluidic":[302],"chamber":[304],"wherein":[305],"perfused":[308],"over":[309],"umbilical":[311],"vein":[312],"(HUVEC)":[315],"monolayers":[316],"treated":[317],"TNF\u03b1":[319],"induce":[321],"expression.":[323],"Consistent":[324],"surface":[329,368,555],"levels,":[331],"robust":[335],"rolling":[336],"interactions":[337,434],"TNF\u03b1-stimulated":[339,436],"HUVECs,":[340],"whereas":[341],"exhibit":[347],"essentially":[348],"no":[349],"interactions.":[351],"overcome":[353],"shortfall,":[355],"assessed":[357],"can":[361,463,550],"be":[362,464,551],"enforced":[363,473,552],"via":[369,466],"glycoengineering":[370,566],"using":[371],"glycosyltransferase":[372],"programmed":[373],"stereosubstitution":[374],"(GPS),":[375],"i.e.,":[376],"fucosyltransferase-mediated":[377],"\u03b1(1,3)-fucose":[378],"installation":[379],"converts":[381],"terminal":[382],"sialylated":[383],"type":[384],"2":[385],"lactosamines":[386],"GPS":[389],"engenders":[390],"markedly":[391,429],"increased":[392],"expression,":[396],"yielding":[397],"full":[398],"(100%)":[399],"-expression":[401],"increasing":[408],"from":[411],"baseline":[413],"20-30%":[415],"maximally":[417],"60-70%":[418],"populations.":[423],"The":[424],"glycoengineered":[425],"enhanced":[430],"(>20":[431],"fold)":[432],"adhesive":[433],"unfucosylated":[443],"T-cells.":[445],"Collectively,":[446],"our":[447],"data":[448,537],"indicate":[449],"induces":[453],"down-regulation":[454],"endogenous":[456],"\u03b1(1,3)-fucosylation,":[457],"and,":[458],"importantly,":[459],"missing":[461],"fucose":[462],"restored":[465],"GPS.":[467],"Finally,":[468],"assess":[470],"binding":[475,545,559],"has":[476],"meaningful":[478],"biologic":[479],"effect,":[480],"examined":[482],"homing":[483],"GPS-modified":[485,509],"bearing":[490],"bed":[491],"(marrow)":[492],"within":[493],"24":[494],"hours":[495],"intravenous":[497],"administration.":[498],"consistently":[500],">3-fold":[502],"increase":[503],"infiltrates":[506],"culture-expanded":[508],"their":[513],"unmodified":[514],"counterparts.":[515],"Overall,":[516],"results":[518],"draw":[519],"attention":[520],"inherent":[523],"inability":[524],"migrate":[529],"sites":[531],"where":[532],"they":[533],"needed.":[535],"Our":[536],"reveal":[538],"capacity,":[546],"however,":[547],"glycoengineering.":[556],"Improved":[557],"yields":[560],"superior":[561],"tissue":[562],"colonization.":[563],"As":[564],"such,":[565],"may":[569],"translate":[570],"into":[571],"lowering":[572],"dosing,":[575],"thereby":[576],"improving":[577],"both":[578,585],"efficacy":[580],"safety,":[582],"reducing":[584],"clinical":[589],"care":[590],"costs,":[591],"promising":[594],"approach.":[596],"Disclosures":[597],"Maus:":[598],"kite":[599],"therapeutics:":[600,605,608],"Consultancy,":[601,609,613],"Research":[602,610,614],"Funding;":[603,611,615],"windmil":[604],"Consultancy;":[606,617],"crispr":[607],"agentus:":[612],"novartis:":[616],"adaptimmune:":[618],"Consultancy.":[619],"Sackstein:Warrior":[620],"Therapeutics":[621],"LLC:":[622],"Equity":[623],"Ownership,":[624],"Patents":[625],"&":[626],"Royalties.":[627]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2912928331","counts_by_year":[],"updated_date":"2026-10-18T09:31:52.927876","created_date":"2019-02-21T00:00:00"}
